ARCHIVES

Chabner Criticizes FDA Crackdown On Off-Label Info

This article is from The Cancer Letter archive.

Vol. 17 No. 26 | June 28, 1991

Download PDF Visit The Full Archive

Related Articles

In Brief: DeVita, FDA Chief Help Kill California Bill Legalizing Laetrile Wit committee Testimony

August 26, 1977

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

January 30, 2009

NCI Gets Withheld Funds; Hazleton Tops List In Stepped-Up Award Flow

April 4, 1975

Cancer Letter Founder Receives ACCC Award, Stresses Importance Of Bypass Budget

March 20, 1992

In Brief: Breast Cancer Detection Concept Was For Grants, Not Contracts; Wallens Gets Five Years Probation

November 16, 1984

How a two-faced media covered cancer: Promoting research—and cigarettes

April 29, 2022